Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology

Mireia Casasampere, Yadira F. Ordoñez, Ana Pou, Josefina Casas

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

28 Citas (Scopus)

Resumen

Dihydroceramide desaturase (Des1) is the last enzyme in the de novo synthesis of ceramides (Cer). It catalyzes the insertion of a double bond into dihydroceramides (dhCer) to convert them to Cer, both of which are further metabolized to more complex (dihydro) sphingolipids. For many years dhCer have received poor attention, mainly due to their supposed lack of biological activity. It was not until about ten years ago that the concept that dhCer might have regulatory roles in biology emerged for the first time. Since then, multiple publications have established that dhCer are implicated in a wide spectrum of biological processes. Physiological and pathophysiological functions of dhCer have been recently reviewed. In this review we will focus on the biochemical features of Des1 and on its inhibition by different compounds with presumably different modes of action.

Idioma originalInglés
Páginas (desde-hasta)33-44
Número de páginas12
PublicaciónChemistry and Physics of Lipids
Volumen197
DOI
EstadoPublicada - may. 2016
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2015 Elsevier Ireland Ltd. All rights reserved.

Huella

Profundice en los temas de investigación de 'Inhibitors of dihydroceramide desaturase 1: Therapeutic agents and pharmacological tools to decipher the role of dihydroceramides in cell biology'. En conjunto forman una huella única.

Citar esto